The following article was published in Breast Investigators in January of 2013. However, I wanted to post it on our blog after listening to comments by a speaker at the MD Anderson Network conference today. The speaker was a Pulitzer prize winner, Siddhartha...
The Food and Drug Administration approved a new type of drug that combines the widely used breast cancer medicine Herceptin with a powerful toxin to more effectively kill cancer cells while potentially reducing side effects. The drug, which will be called Kadcyla but...
